AZN | AstraZeneca COVID-19 Vaccine Could Be Ready for Large-Scale Immunization as Early as December, Says CEO 8th November 2020 – (Cambridge) AstraZeneca Plc (Cambridgeshire, England) expects test results from its COVID-19 vaccine candidate within the next eight weeks and hopes to begin large-scale vaccinations as early as this year.Trials of AstraZeneca’s adenovirus vector-based COVID-19 vaccine candidate, AZD1222, developed by the University of Oxford (Oxford, UK), were delayed slightly over […] […]